Anticavity Fluoride Rinse

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children aged 6 years and older are instructed to use the rinse once daily, following the brushing of teeth with toothpaste.

To prepare the rinse, the cap should be removed, and 10 milliliters (mL) of the solution should be poured, ensuring that the liquid does not exceed the 10 mL mark indicated on the inside of the cap. The user should then vigorously swish the 10 mL of rinse between the teeth for a duration of 1 minute before spitting it out. It is imperative that the rinse is not swallowed.

After rinsing, patients should refrain from eating or drinking for 30 minutes to allow for optimal efficacy of the product.

For children under 12 years of age, it is essential to instruct them in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision may be required until the child is capable of using the product without assistance. For children under 6 years of age, consultation with a dentist or physician is recommended prior to use.

Contraindications

Use is contraindicated if more than the recommended amount for rinsing is accidentally swallowed. In such cases, seek professional assistance or contact a Poison Control Center immediately.

Warnings and Precautions

For this product, it is imperative to adhere to the following warnings and precautions to ensure safe usage.

General precautions should be observed, including the necessity to keep the product out of reach of children to prevent accidental ingestion or misuse.

In the event that more than the recommended amount for rinsing is accidentally swallowed, it is crucial to seek emergency medical assistance or contact a Poison Control Center immediately. Prompt action is essential to mitigate any potential adverse effects.

Currently, there are no specified laboratory tests recommended for monitoring during the use of this product. However, healthcare professionals should remain vigilant and provide guidance to patients regarding the safe use of the product.

Side Effects

Patients should be aware that there are no specific adverse reactions listed for this product. However, it is important to note that if more than the recommended amount used for rinsing is accidentally swallowed, immediate professional assistance should be sought, or a Poison Control Center should be contacted. This precaution is critical to ensure the safety and well-being of individuals using the product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Anticavity Fluoride Rinse (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be instructed to keep the product out of reach of children. In the event that more than the recommended amount for rinsing is accidentally swallowed, professional assistance or contact with a Poison Control Center should be sought immediately.

For children aged 6 years and older, the product is to be used once daily after brushing teeth with toothpaste. It is important to instruct children under 12 years of age in proper rinsing habits to minimize the risk of swallowing. Supervision may be necessary until children are capable of using the product without assistance.

For children under 6 years of age, consultation with a dentist or doctor is recommended prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use. There may be potential risks associated with the use of sodium fluoride during pregnancy; further studies are needed to determine safety and potential fetal impacts. No specific dosage modifications for pregnant individuals are provided; therefore, it is advisable for healthcare professionals to offer personalized advice based on individual circumstances.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is critical to seek professional assistance or contact a Poison Control Center immediately if more than the recommended amount used for rinsing is accidentally swallowed.

Healthcare professionals should be aware that prompt action is essential in managing potential overdosage situations. Symptoms may vary depending on the specific substance involved, and monitoring for adverse effects is advised.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to ensure appropriate interventions are implemented.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that if more than the recommended amount used for rinsing is accidentally swallowed, it is crucial to seek professional assistance or contact a Poison Control Center immediately. This information is essential for ensuring patient safety and prompt action in case of accidental ingestion.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The medication is administered orally. Clinicians should counsel patients to keep the product out of reach of children and to seek professional assistance or contact a Poison Control Center immediately if more than the recommended amount is accidentally swallowed. It is important to instruct children under 12 years of age on proper rinsing techniques to minimize swallowing and to supervise them as necessary until they can use the product independently. For children under 6 years of age, consultation with a dentist or doctor is advised.

Drug Information (PDF)

This file contains official product information for Anticavity Fluoride Rinse, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)